Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Primary Chemotherapy With Anthracycline-based Regimen Followed by Nab-paclitaxel and Trastuzumab in Patients With HER2 Positive Breast Cancer

NCT01432223 is registered in ClinicalTrials.gov with Osaka Medical College as lead sponsor.

NCT NCT01432223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01432223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Primary Chemotherapy With Anthracycline-based Regimen Followed by Nab-paclitaxel and Trastuzumab in Patients With HER2 Positive Breast Cancer
Lead sponsor
Osaka Medical College
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2011
Completion date
May 31, 2014
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, effects of chemotherapy, her-2 positive breast cancer